Germany · Series C startup

Who invested in Omeicos Therpeutics

One round we have observed, with the 7 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$19Mraised across 1 round since 2018, from 1 source

Latest round: Series C, $19MNov 2018
Investors: 7

See who backed them

The rounds

Nov 2018
Series C$19M
- HTGF High-Tech Gründerfonds
- VC Fonds Technologie Berlin
- The Falck Revocable Trust
- Forbion/ Vesalius Biocapital II S.A. SICAR
- KFW Group
- Remiges BioPharma Fund
- SMS Group GmbH
Reported by FinSMEs

Everyone who backed them

HTGF High-Tech GründerfondsVC firm1round

VC Fonds Technologie BerlinVC firm1round

The Falck Revocable TrustGrowth equity1round

Forbion/ Vesalius Biocapital II S.A. SICARno record of our own yet1round

KFW Groupno record of our own yet1round

Remiges BioPharma Fundno record of our own yet1round

SMS Group GmbHno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Omeicos Therpeutics

Who invested in Omeicos Therpeutics?

Omeicos Therpeutics's investors include HTGF High-Tech Gründerfonds, VC Fonds Technologie Berlin, The Falck Revocable Trust, Forbion/ Vesalius Biocapital II S.A. SICAR and KFW Group, and 2 more on record.

How much has Omeicos Therpeutics raised?

Omeicos Therpeutics has raised $19M across 1 round since 2018.

When did Omeicos Therpeutics last raise?

Omeicos Therpeutics's most recent round was a Series C of $19M in Nov 2018.

What was Omeicos Therpeutics's biggest round?

Its most recent round, $19M in Nov 2018, is also its largest on record.

Who backed Omeicos Therpeutics first?

Omeicos Therpeutics's first round on record, in Nov 2018, was backed by HTGF High-Tech Gründerfonds, VC Fonds Technologie Berlin and The Falck Revocable Trust and 4 others.